Schrödinger, Inc. (SDGR)

NMS – Real vaqt narxi. Valyuta: USD

12.60

-0.09 (-0.71%)

Bozor ochiq: May 13, 2026, 9:36 AM EDT

06.05.2026

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

05.05.2026

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.82 per share a year ago.

05.05.2026

Schrödinger Reports First Quarter 2026 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. announced financial results for the quarter ended March 31, 2026.

04.05.2026

Schrödinger to Participate in Upcoming Investor Conferences

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in May: BofA Securities 2026 Healthcare Conference: Fireside chat on Wednesday, May 13, 2026, at 5:20 p.m. E.T. RBC 2026 Global Healthcare Conference: Fireside chat on Tuesday, May 19, 2026 at 2:05 p.m. E.T. The live discussions can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the eve.

21.04.2026

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) will report its first quarter 2026 financial results on Tuesday, May 5, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming molecular discovery with its computational platform, which.

17.04.2026

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on April 16, 2026, the company granted restricted stock units (RSUs) with respect to 4,253 shares of the company's common stock to four newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company's board of directors, and were made as a material inducement t.

23.03.2026

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Videolar

No Data

There is no data to display

Press-relizlar

05.05.2026

Schrödinger Reports First Quarter 2026 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. announced financial results for the quarter ended March 31, 2026.

17.04.2026

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

18.03.2026

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 14, 2026, the company granted (i) a non-statutory stock option to purchase 1,950 shares of the company's common stock to one newly hired employee and (ii) restricted stock units (RSUs) with respect to 4,375 shares of the company's common stock to two newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of t.

25.02.2026

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the fourth quarter and full-year ended December 31, 2025, and provided its 2026 outlook and 2028 financial objectives. "Schrödinger's performance in 2025, marked by 23% total revenue growth and 11% software revenue growth, is a testament to the resilience of our business and the unique value we provide," said Ramy Farid, Ph.D., chief executive officer of Schrödinger. “While the drug discovery AI la.

Schrödinger, Inc. (SDGR)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Schrödinger, Inc. (SDGR)

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

Schrödinger Reports First Quarter 2026 Financial Results

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Videolar

No Data

Press-relizlar

Schrödinger Reports First Quarter 2026 Financial Results

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

Schrödinger Reports First Quarter 2026 Financial Results

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Videolar

No Data

Press-relizlar

Schrödinger Reports First Quarter 2026 Financial Results

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

Search stocks

Schrödinger, Inc. (SDGR)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Schrödinger, Inc. (SDGR)

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

Schrödinger Reports First Quarter 2026 Financial Results

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Videolar

No Data

Press-relizlar

Schrödinger Reports First Quarter 2026 Financial Results

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

Schrödinger Reports First Quarter 2026 Financial Results

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Videolar

No Data

Press-relizlar

Schrödinger Reports First Quarter 2026 Financial Results

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results